display
Hamburg (dpa / lno) - Because of the production and sale of a non-approved cancer drug, a 72-year-old must appear before the Hamburg district court from today (9:30 a.m.).
The public prosecutor's office accuses the molecular biologist of having sold the drug GcMAF to doctors and alternative practitioners in Germany and abroad from January 2014 to May 2017.
The accused was neither licensed as a doctor or pharmacist, nor did he have a license to manufacture the agent in his laboratory (Az. 624 KLs 8/19).
The customers each had to fill out a form in which they truthfully stated that they had manufactured the drug themselves.
In this way the Medicines Act should be circumvented.
The public prosecutor's office assumes 400 deliveries, through which the defendant raised over 1.9 million euros.
The drug GcMAF may be manufactured and administered individually for patients by doctors and alternative practitioners, said a court spokesman.
It is used for immunotherapy, which is why it is difficult to prove its effectiveness.
A license is required in any case for the production of the agent for intravenous administration.
display
© dpa-infocom, dpa: 210216-99-467730 / 2